Myriad Genetics
MYGN
MYGN
221 hedge funds and large institutions have $2.23B invested in Myriad Genetics in 2019 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 71 increasing their positions, 79 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% less call options, than puts
Call options by funds: $11.7M | Put options by funds: $13.8M
29% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 45
Holders
221
Holding in Top 10
2
Calls
$11.7M
Puts
$13.8M
Top Buyers
| 1 | +$105M | |
| 2 | +$97M | |
| 3 | +$28.6M | |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
+$22.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.35M |
Top Sellers
| 1 | -$47.7M | |
| 2 | -$35M | |
| 3 | -$24.2M | |
| 4 |
D.E. Shaw & Co
New York
|
-$23.5M |
| 5 |
State Street
Boston,
Massachusetts
|
-$15.7M |